MacroGenics (MGNX) director granted options and RSUs, RSUs vest into shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
MACROGENICS INC director Karen Jean Ferrante reported equity compensation transactions. On May 19, 2026, she received a stock option grant for 22,000 shares of common stock at an exercise price of $4.52 per share, expiring on May 19, 2036. She also received 3,750 restricted stock units (RSUs), each representing one future share of common stock, which vest one year after grant or the day before the next annual meeting, if earlier. On May 18, 2026, 3,750 RSUs vested and were converted into 3,750 shares of common stock, increasing her direct common stock holdings to 14,750 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,750 shares exercised/converted
Mixed
4 txns
Insider
Ferrante Karen Jean
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 3,750 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 22,000 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 3,750 | $0.00 | -- |
| Exercise | Common Stock | 3,750 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Unit — 3,750 shares (Direct, null);
Stock Option (right to buy) — 22,000 shares (Direct, null);
Common Stock — 14,750 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026. The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
Key Figures
Stock options granted: 22,000 shares
Option exercise price: $4.52 per share
Option expiration: May 19, 2036
+4 more
7 metrics
Stock options granted
22,000 shares
Option grant to director on May 19, 2026
Option exercise price
$4.52 per share
Exercise price of 22,000-share option grant
Option expiration
May 19, 2036
Expiry date of stock option grant
RSUs granted
3,750 units
New RSU award on May 19, 2026
RSUs vested and exercised
3,750 units
RSUs vested and converted on May 18, 2026
Common shares after transaction
14,750 shares
Direct MACROGENICS common stock held post-transaction
Derivative exercises
1 transaction, 3,750 shares
Exercise of RSUs into common stock
Key Terms
Restricted Stock Unit, Stock Option, vested, derivative security
4 terms
Restricted Stock Unit financial
"The RSUs vested on May 18, 2026, which was one day prior..."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option financial
"The option will vest and become exercisable in monthly, cumulative 1/12th increments..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vested financial
"The RSUs vested on May 18, 2026, which was one day prior..."
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What equity awards did MACROGENICS (MGNX) director Karen Ferrante receive?
Karen Ferrante received a stock option for 22,000 shares at an exercise price of $4.52 per share and 3,750 restricted stock units, each representing one future share of MACROGENICS common stock as part of her director compensation.
When do Karen Ferrante’s new MACROGENICS (MGNX) RSUs vest?
The newly granted 3,750 RSUs will vest one year after the May 19, 2026 grant date, or on the day prior to the next annual meeting, if that occurs earlier, according to the vesting terms disclosed for these restricted stock units.
What happened to Karen Ferrante’s previously granted MACROGENICS (MGNX) RSUs?
Previously granted RSUs totaling 3,750 units vested on May 18, 2026, one day before MACROGENICS’ 2026 annual meeting. Upon vesting, they were converted into 3,750 shares of common stock, increasing her direct share ownership.
What are the key terms of Karen Ferrante’s new MACROGENICS (MGNX) stock options?
The stock options cover 22,000 shares of MACROGENICS common stock at a $4.52 exercise price and expire on May 19, 2036. They vest in monthly, cumulative 1/12th increments starting one month after the May 19, 2026 grant date.
How do the MACROGENICS (MGNX) RSUs reported for Karen Ferrante function?
Each RSU represents a contingent right to receive one share of MACROGENICS common stock. RSUs vest on specified dates, such as one year after grant, and upon vesting they convert into common shares that increase the holder’s direct share ownership.